Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 65-77

Bentham Science Publishers

Access to resources Recommend Favorite

Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy

By Wheler J. J.   Falchook G. S.   Tsimberidou A. M.   Hong D. S.   Naing A.   Piha-Paul S. A.   Chen S. S.   Fu S.   Stephen B.   Fok J. Y.   Janku F.   Kurzrock R.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 838-842

Oxford University Press

Access to resources Recommend Favorite

Targeting the epidermal growth factor receptor: prognostic and clinical implications

By Herbst R.  

EJC Supplements, Vol. 1, Iss. 8, 2003-10 ,pp. : 9-15

Elsevier

Access to resources Recommend Favorite

Multiple Infusions of Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (EMD 55 900) in Patients with Recurrent Malignant Gliomas

By Stragliotto G.   Vega F.   Stasiecki P.   Gropp P.   Poisson M.   Delattre J.-Y.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 636-640

Elsevier

Access to resources Recommend Favorite

Can we predict the response to epidermal growth factor receptor targeted therapy?

By Manegold Philipp  

Targeted Oncology, Vol. 3, Iss. 2, 2008-04 ,pp. : 87-99

Springer Publishing Company

Access to resources Recommend Favorite